CardioMEMS welcomes $33m capital and new CFO:
This article was originally published in Clinica
Executive Summary
Atlanta, Georgia-based CardioMEMS has completed a $33m series E financing led by Arcapita Ventures. Existing CardioMEMS shareholders, as well as new investors Deerfield Capital Management, Vision Capital Advisors, Aperture Venture Partners and Rockport Venture Securities, also participated in the round. CardioMEMS develops wireless sensing technologies is designed to eliminate the need for leads and batteries when managing severe chronic cardiovascular diseases. It intends to use the capital to advance clinical trials of its product.